Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-33 inhibitor Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pulmonary Disease, Chronic Obstructive 3 D029424 ClinicalTrials
Asthma 2 D001249 ClinicalTrials
Dermatitis, Atopic 2 D003876 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594594
FDA SRS WV9KZ9PS1A